Our data shows that PALB2 pathogenic germline mutations are not present in a Chilean population, and that rs152451 and rs45551636 are associated with increased BC risk in BRCA1/2- negative families with a strong family history of BC but not in non-familial early-onset BC. This evidence concerns the gene BRCA1 and breast cancer.